FDA Grants Approval for Tofacitinib Citrate ANDA219830 by Orient Pharma
The FDA has granted approval for the ANDA219830 application for Tofacitinib Citrate submitted by Orient Pharma.
Company
Pharmaceutical intelligence for Orient Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.